cambridgecognition.com Open in urlscan Pro
77.68.77.215  Public Scan

Form analysis
1 forms found in the DOM

GET https://cambridgecognition.com/

<form data-min-no-for-search="1" data-result-box-max-height="400" data-form-id="26778" class="is-search-form is-form-style is-form-style-3 is-form-id-26778 is-ajax-search" action="https://cambridgecognition.com/" method="get" role="search"><label
    for="is-search-input-26778"><span class="is-screen-reader-text">Search for:</span><input type="search" id="is-search-input-26778" name="s" value="" class="is-search-input" placeholder="Search here..." autocomplete="off"><span
      class="is-loader-image" style="display: none;background-image:url(https://cambridgecognition.com/wp-content/plugins/add-search-to-menu/public/images/spinner.gif);"></span></label><button type="submit" class="is-search-submit"><span
      class="is-screen-reader-text">Search Button</span><span class="is-search-icon"><svg focusable="false" aria-label="Search" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="24px">
        <path
          d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
        </path>
      </svg></span></button><input type="hidden" name="id" value="26778"></form>

Text Content

We value your privacy

We use cookies to enhance your browsing experience, serve personalised ads or
content, and analyse our traffic. By clicking "Accept All", you consent to our
use of cookies.

Customize Reject All Accept All
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions.
You will find detailed information about all cookies under each consent category
below.

The cookies that are categorized as "Necessary" are stored on your browser as
they are essential for enabling the basic functionalities of the site.... Show
more

NecessaryAlways Active

Necessary cookies are required to enable the basic features of this site, such
as providing secure log-in or adjusting your consent preferences. These cookies
do not store any personally identifiable data.

No cookies to display.

Functional

Functional cookies help perform certain functionalities like sharing the content
of the website on social media platforms, collecting feedback, and other
third-party features.

No cookies to display.

Analytics

Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics such as the number of
visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance

Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.

No cookies to display.

Advertisement

Advertisement cookies are used to provide visitors with customized
advertisements based on the pages you visited previously and to analyze the
effectiveness of the ad campaigns.

No cookies to display.

Reject All Save My Preferences Accept All
Powered by
Skip to content

Search for:Search Button



Main Menu MENU
Main Menu MENU



TECHNOLOGY TO ACCURATELY ASSESS BRAIN HEALTH

Anytime, anywhere



Backed by over 30 years of scientific discovery and validation, Cambridge
Cognition offers the end-to-end platform for CNS clinical trials.
Our technologies are reliable in-clinic or at home for an improved patient
experience and accelerated drug development.


TRUSTED BY THE WORLD’S TOP RESEARCHERS

Leading pharmaceutical organisations, research institutions and healthcare
professionals around the world rely on us to consistently deliver accurate and
highly sensitive assessments that are capable of detecting even subtle cognitive
changes.

ACADEMIC RESEARCH


DRUG DEVELOPMENT


30+ YEARS' EXPERIENCE IN ASSESSMENT TECHNOLOGY

Delivering leading digital cognitive assessments, decentralised clinical trials
platform and healthcare tools, our team of neuroscientists and data specialists,
consultants and project managers will help you design and deliver a study that
fulfils your research goals and assess patients accurately.

0 +
indications
assessed using
our technologies
1 m+
patients
assessed on our
digital health tools
0

digital cognitive
assessments

0 +

peer reviewed
papers & articles


OUR TECHNOLOGIES

The world’s top pharmaceutical organisations, research institutions and
healthcare professionals trust our technologies to consistently deliver highly
sensitive and accurate results.


TOUCHSCREEN COGNITIVE ASSESSMENTS


Highly sensitive and scientifically validated digital cognitive assessments.
Learn more


VOICE
ANALYSIS


Automated scoring of verbal cognitive assessments utilising cutting-edge
technologies.
Learn more


ELECTRONIC QUESTIONNAIRES & SCALES


Digital administration of established and bespoke questionnaires and scales.
Learn more


HIGH FREQUENCY
TESTING


Capture day-to-day cognitive function with short accessible tasks deployed at
regular intervals throughout the day.
Learn more


DECENTRALISED
CLINICAL TRIALS


Seamless end-to-end study management from site to patient, from recruitment
through to data collection and reporting.
Learn more


RATINGS QUALITY
ASSURANCE



Rapid, cost-effective scale review to ensure high-quality data and your trial’s
best chance at success

Learn more



THERAPEUTIC EXPERTISE

Since CANTAB® was first developed, our digital cognitive assessments have been
validated in over 3,000 publications and more than 250 indications. Take a
closer look at some of the therapeutic areas that have benefitted from our
expertise.

Try CANTAB web-based testing *

ALZHEIMER'S DISEASE

MULTIPLE SCLEROSIS

ADHD

DEPRESSION

SCHIZOPHRENIA

More therapeutic areas


SELECT A THERAPEUTIC AREA BELOW TO FIND OUT MORE

ADHD

Alzheimer’s disease

Autism spectrum disorder

Cognitive safety

Core cognitive function

Depression

Down’s syndrome

Drug abuse liability

Epilepsy

Huntington’s disease
 
Multiple sclerosis
 
Neuromuscular disorders
 
Obsessive compulsive disorder
 
Parkinson’s disease
 
Schizophrenia
 
Stroke & cerebrovascular disease
 
Traumatic brain injury





More therapeutic areas


OUR THERAPEUTIC EXPERTISE

ADHD

Alzheimer’s disease

Autism spectrum disorder

Cognitive safety

Core cognitive function

Depression

Down’s syndrome

Drug abuse liability

Epilepsy

Huntington’s disease

Multiple sclerosis

Neuromuscular disorders

Obsessive compulsive disorder

Parkinson’s disease

Schizophrenia

Stroke & cerebrovascular disease

Traumatic brain injury







LATEST RESEARCH NEWS

23 April 2024
Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for
schizophrenia clinical development
16 April 2024
2023 CANTAB Research Grant: Exploring the role of intermittent exogenous ketosis
on physical and mental fatigue during ultra-endurance performance
10 April 2024
Cambridge Cognition strengthens senior management team to deliver growth
16 May 2024
New partnership with the University of Essex to strengthen CANTAB® normative
data offering
30 April 2024
Cambridge Cognition and The Michael J. Fox Foundation to employ digital
cognitive assessments in unraveling the mysteries of Parkinson’s disease
29 April 2024
Supporting research into central nervous system (CNS) disorders to improve
patient quality of life
23 April 2024
Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for
schizophrenia clinical development
16 April 2024
2023 CANTAB Research Grant: Exploring the role of intermittent exogenous ketosis
on physical and mental fatigue during ultra-endurance performance
10 April 2024
Cambridge Cognition strengthens senior management team to deliver growth
16 May 2024
New partnership with the University of Essex to strengthen CANTAB® normative
data offering
30 April 2024
Cambridge Cognition and The Michael J. Fox Foundation to employ digital
cognitive assessments in unraveling the mysteries of Parkinson’s disease
29 April 2024
Supporting research into central nervous system (CNS) disorders to improve
patient quality of life




CONTACT US

Our neuroscience specialists and product experts are on hand to answer your
questions.

Get in touch



CONTACT US


 * What we do Menu Toggle
   * For drug development
   * Study design
   * Patient experience
   * Study management & support
   * Data management & reporting
   * space
   * For academic research
   * Technology & delivery
   * Support
 * Our technologies Menu Toggle
   * Digital cognitive assessments
   * CANTAB®
   * space
   * Electronic questionnaires & scales
   * eCOA
   * space
   * Voice analysis
   * NeuroVocalix™ | Winterlight
   * space
   * High frequency testing
   * Cognition Kit™
   * space
   * Decentralised clinical trials
   * Clinpal
   * eConsent
   * Space
   * Ratings quality assurance
   * AQUA
 * Our science Menu Toggle
   * By therapeutic area
   * ADHD
   * Alzheimer’s disease
   * Autism spectrum disorder
   * Cognitive safety
   * Core cognitive function
   * Depression
   * Down’s syndrome
   * Drug abuse liability
   * Epilepsy
   * Huntington’s disease
   * Multiple sclerosis
   * Neuromuscular disorders
   * Obsessive compulsive disorder
   * Parkinson’s disease
   * Schizophrenia
   * Stroke & cerebrovascular disease
   * Traumatic brain injury
 *   Menu Toggle
   * By cognitive function
   * Attention & psychomotor speed
   * Emotion & social cognition
   * Executive function
   * Memory
   * space
   * Resources
   * Bibliography
   * Insights
   * Publications & posters
   * eBooks & whitepapers
   * Webinars
   * Events
 * About us Menu Toggle
   * News
   * Regulatory compliance
   * space
   * Careers
   * space
   * Investor centre
   * space
   * Contact us

 * What we do Menu Toggle
   * For drug development
   * Study design
   * Patient experience
   * Study management & support
   * Data management & reporting
   * space
   * For academic research
   * Technology & delivery
   * Support
 * Our technologies Menu Toggle
   * Digital cognitive assessments
   * CANTAB®
   * space
   * Electronic questionnaires & scales
   * eCOA
   * space
   * Voice analysis
   * NeuroVocalix™ | Winterlight
   * space
   * High frequency testing
   * Cognition Kit™
   * space
   * Decentralised clinical trials
   * Clinpal
   * eConsent
   * Space
   * Ratings quality assurance
   * AQUA
 * Our science Menu Toggle
   * By therapeutic area
   * ADHD
   * Alzheimer’s disease
   * Autism spectrum disorder
   * Cognitive safety
   * Core cognitive function
   * Depression
   * Down’s syndrome
   * Drug abuse liability
   * Epilepsy
   * Huntington’s disease
   * Multiple sclerosis
   * Neuromuscular disorders
   * Obsessive compulsive disorder
   * Parkinson’s disease
   * Schizophrenia
   * Stroke & cerebrovascular disease
   * Traumatic brain injury
 *   Menu Toggle
   * By cognitive function
   * Attention & psychomotor speed
   * Emotion & social cognition
   * Executive function
   * Memory
   * space
   * Resources
   * Bibliography
   * Insights
   * Publications & posters
   * eBooks & whitepapers
   * Webinars
   * Events
 * About us Menu Toggle
   * News
   * Regulatory compliance
   * space
   * Careers
   * space
   * Investor centre
   * space
   * Contact us

Email

Drug development

Academic research

Healthcare

Technology
Cognitive expertise
Resources

About us
Investor centre
Contact

Privacy policy | Terms of use

© Copyright 2023    Cambridge Cognition Ltd | All rights reserved | Registered
in England and Wales | Company no. 4338746




 * 
   What we do
   * 
     For drug development
   * 
     Study design
   * 
     Patient experience
   * 
     Study management & support
   * 
     Data management & reporting
   * 
     space
   * 
     For academic research
   * 
     Technology & delivery
   * 
     Support
 * 
   Our technologies
   * 
     Digital cognitive assessments
   * 
     CANTAB®
   * 
     space
   * 
     Electronic questionnaires & scales
   * 
     eCOA
   * 
     space
   * 
     Voice analysis
   * 
     NeuroVocalix™ | Winterlight
   * 
     space
   * 
     High frequency testing
   * 
     Cognition Kit™
   * 
     space
   * 
     Decentralised clinical trials
   * 
     Clinpal
   * 
     eConsent
   * 
     Space
   * 
     Ratings quality assurance
   * 
     AQUA
 * 
   Our science
   * 
     By therapeutic area
   * 
     ADHD
   * 
     Alzheimer’s disease
   * 
     Autism spectrum disorder
   * 
     Cognitive safety
   * 
     Core cognitive function
   * 
     Depression
   * 
     Down’s syndrome
   * 
     Drug abuse liability
   * 
     Epilepsy
   * 
     Huntington’s disease
   * 
     Multiple sclerosis
   * 
     Neuromuscular disorders
   * 
     Obsessive compulsive disorder
   * 
     Parkinson’s disease
   * 
     Schizophrenia
   * 
     Stroke & cerebrovascular disease
   * 
     Traumatic brain injury
 * 
    
   * 
     By cognitive function
   * 
     Attention & psychomotor speed
   * 
     Emotion & social cognition
   * 
     Executive function
   * 
     Memory
   * 
     space
   * 
     Resources
   * 
     Bibliography
   * 
     Insights
   * 
     Publications & posters
   * 
     eBooks & whitepapers
   * 
     Webinars
   * 
     Events
 * 
   About us
   * 
     News
   * 
     Regulatory compliance
   * 
     space
   * 
     Careers
   * 
     space
   * 
     Investor centre
   * 
     space
   * 
     Contact us




Scroll to Top